These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 23884066)

  • 1. Understanding barriers to hepatitis C virus care and stigmatization from a social perspective.
    Treloar C; Rance J; Backmund M
    Clin Infect Dis; 2013 Aug; 57 Suppl 2():S51-5. PubMed ID: 23884066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The depiction of stigmatization in research about hepatitis C.
    Paterson BL; Backmund M; Hirsch G; Yim C
    Int J Drug Policy; 2007 Oct; 18(5):364-73. PubMed ID: 17854724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discrimination by health care workers versus discrimination by others: countervailing forces on HCV treatment intentions.
    Brener L; Horwitz R; von Hippel C; Bryant J; Treloar C
    Psychol Health Med; 2015; 20(2):148-53. PubMed ID: 24889417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Living with the stigma of hepatitis C.
    Butt G; Paterson BL; McGuinness LK
    West J Nurs Res; 2008 Mar; 30(2):204-21; discussion 222-33. PubMed ID: 17630381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uptake and delivery of hepatitis C treatment in opiate substitution treatment: perceptions of clients and health professionals.
    Treloar C; Newland J; Rance J; Hopwood M
    J Viral Hepat; 2010 Dec; 17(12):839-44. PubMed ID: 20070504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stigma in the context of hepatitis C: concept analysis.
    Butt G
    J Adv Nurs; 2008 Jun; 62(6):712-24. PubMed ID: 18503656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Understanding social stigma in women with hepatitis C.
    Grundy G; Beeching N
    Nurs Stand; 2004 Oct 6-12; 19(4):35-9. PubMed ID: 15521414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Discrimination perceived by people with a diagnosis of schizophrenic disorders. INternational study of DIscrimination and stiGma Outcomes (INDIGO): French results].
    Daumerie N; Vasseur Bacle S; Giordana JY; Bourdais Mannone C; Caria A; Roelandt JL
    Encephale; 2012 Jun; 38(3):224-31. PubMed ID: 22726410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 'Makes you wanna do treatment': benefits of a hepatitis C specialist clinic to clients in Christchurch, New Zealand.
    Brener L; Gray R; Cama EJ; Treloar C
    Health Soc Care Community; 2013 Mar; 21(2):216-23. PubMed ID: 23199074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The drugs that dare not speak their name: Injecting and other illicit drug use during treatment for hepatitis C infection.
    Hopwood M; Treloar C
    Int J Drug Policy; 2007 Oct; 18(5):374-80. PubMed ID: 17854725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Challenging stereotypes and changing attitudes: Improving quality of care for people with hepatitis C through Positive Speakers programs.
    Brener L; Wilson H; Rose G; Mackenzie A; de Wit J
    Psychol Health Med; 2013; 18(2):242-9. PubMed ID: 22783938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experiences of diagnosis, care and treatment among Aboriginal people living with hepatitis C.
    Brener L; Wilson H; Jackson LC; Johnson P; Saunders V; Treloar C
    Aust N Z J Public Health; 2016 Apr; 40 Suppl 1():S59-64. PubMed ID: 26123616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A dirty little secret: stigma, shame and hepatitis C in the health setting.
    Northrop JM
    Med Humanit; 2017 Dec; 43(4):218-224. PubMed ID: 28363990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural factors that promote stigmatization of drug users with hepatitis C in hospital emergency departments.
    Paterson B; Hirsch G; Andres K
    Int J Drug Policy; 2013 Sep; 24(5):471-8. PubMed ID: 23453299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Managing uncertainty: a grounded theory of stigma in transgender health care encounters.
    Poteat T; German D; Kerrigan D
    Soc Sci Med; 2013 May; 84():22-9. PubMed ID: 23517700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Taming systems to create enabling environments for HCV treatment: negotiating trust in the drug and alcohol setting.
    Harris M; Rhodes T; Martin A
    Soc Sci Med; 2013 Apr; 83():19-26. PubMed ID: 23465200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prejudice among health care workers toward injecting drug users with hepatitis C: does greater contact lead to less prejudice?
    Brener L; von Hippel W; Kippax S
    Int J Drug Policy; 2007 Oct; 18(5):381-7. PubMed ID: 17854726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient perspectives on hepatitis C and its treatment.
    North CS; Devereaux R; Pollio DE; Hong BA; Jain MK
    Eur J Gastroenterol Hepatol; 2014 Jan; 26(1):74-81. PubMed ID: 23788155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do we need to address stigma and mistrust to facilitate hepatitis C elimination among people living with HIV?
    Cachay E
    AIDS; 2020 Feb; 34(2):325-331. PubMed ID: 31876595
    [No Abstract]   [Full Text] [Related]  

  • 20. Experiences of stigma and discrimination among users of mental health services in Poland.
    Świtaj P; Wciórka J; Grygiel P; Anczewska M; Schaeffer E; Tyczyński K; Wiśniewski A
    Transcult Psychiatry; 2012 Feb; 49(1):51-68. PubMed ID: 22222618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.